A Randomized, Double-Blind, Placebo-Controlled Single-Ascending Dose Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of GWP42003-P in Conjunction with Hypothermia in Neonates with Moderate or Severe Hypoxic Ischemic Encephalopathy
Latest Information Update: 27 Sep 2023
At a glance
- Drugs Cannabidiol (Primary)
- Indications Cerebral ischaemia
- Focus Adverse reactions
- Sponsors GW Research
Most Recent Events
- 27 Sep 2023 This trial was completed in spain, according to European Clinical Trials Database record.
- 23 Oct 2022 This trial was completed in Poland, according to European Clinical Trials Database record.
- 11 Oct 2019 New trial record